Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant® is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer. The Guardant Health Director, Oncology Therapy Selection Products reports to our Senior Director of Product Management and drives market evolution across Guardant Health's liquid biopsy therapy selection portfolio. This is a pivotal role for a strategic and execution-driven leader who thrives at the intersection of product innovation, clinical impact, and commercial growth. You would own product strategy, roadmap execution, and commercial readiness for the Guardant360 Liquid therapy selection products. In addition, you would also shape how these high-impact diagnostics enter and expand within standard of care, accelerate adoption, and stay differentiated in a competitive liquid biopsy market. To be successful, this Director should have a strong clinical science foundation, alongside product management judgment and discernment.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director